New and emerging infectious diseases.
Identifieur interne : 001E63 ( PubMed/Corpus ); précédent : 001E62; suivant : 001E64New and emerging infectious diseases.
Auteurs : Lucia Spicuzza ; Alessandro Spicuzza ; Mario La Rosa ; Riccardo Polosa ; Giuseppe Di MariaSource :
- Allergy and asthma proceedings [ 1088-5412 ]
English descriptors
- KwdEn :
- Adrenal Cortex Hormones (therapeutic use), Antibodies, Viral (analysis), Antiviral Agents (therapeutic use), Communicable Diseases, Emerging, Disease Outbreaks (prevention & control), Global Health, Humans, Influenza A Virus, H5N1 Subtype (genetics), Influenza A Virus, H5N1 Subtype (immunology), Influenza, Human (diagnosis), Influenza, Human (drug therapy), Influenza, Human (epidemiology), Influenza, Human (transmission), Influenza, Human (virology), Polymerase Chain Reaction, Practice Guidelines as Topic, RNA, Viral (analysis), SARS Virus (genetics), SARS Virus (immunology), Serologic Tests, Severe Acute Respiratory Syndrome (diagnosis), Severe Acute Respiratory Syndrome (drug therapy), Severe Acute Respiratory Syndrome (epidemiology), Severe Acute Respiratory Syndrome (transmission), Severe Acute Respiratory Syndrome (virology).
- MESH :
- chemical , analysis : Antibodies, Viral, RNA, Viral.
- chemical , therapeutic use : Adrenal Cortex Hormones, Antiviral Agents.
- diagnosis : Influenza, Human, Severe Acute Respiratory Syndrome.
- drug therapy : Influenza, Human, Severe Acute Respiratory Syndrome.
- epidemiology : Influenza, Human, Severe Acute Respiratory Syndrome.
- genetics : Influenza A Virus, H5N1 Subtype, SARS Virus.
- immunology : Influenza A Virus, H5N1 Subtype, SARS Virus.
- prevention & control : Disease Outbreaks.
- transmission : Influenza, Human, Severe Acute Respiratory Syndrome.
- virology : Influenza, Human, Severe Acute Respiratory Syndrome.
- Communicable Diseases, Emerging, Global Health, Humans, Polymerase Chain Reaction, Practice Guidelines as Topic, Serologic Tests.
Abstract
New emerging infectious diseases include "severe acute respiratory distress syndrome" (SARS) and avian influenza A H5N1. First cases of SARS, induced by a new strain of coronavirus, were described in China in 2002 and by May 2003 8360 cases and 764 deaths were reported by the World Health Organization. The disease can be transmitted from person to person and at the onset is characterized by nonspecific symptoms such as a fever of > 38 degrees C, dry cough, myalgia, and dyspnea. Adults can develop severe hypoxemia requiring intubation, whereas the course of the disease is generally benign in children. Avian influenza A H5N1 is another emerging infectious disease transmitted from avian species to humans, without clear evidence of transmission from human to human. The widespread outbreaks of H5N1 avian influenza in 2003-2004 have caused major problems for the poultry industry in many Asian countries. On January 2004 the disease crossed over to humans, for the first time in Vietnam, causing 74 deaths to date (mortality rate of 50%) in southeastern countries. Unlike SARS, the avian flu occurs in rural areas, where people live in intimate contact with birds, and many of the victims are children < 5 years of age. As for SARS, the World Health Organization has adopted a global action plan to control avian influenza among chickens and ducks and at the same time to limit the threat of a human flu pandemic.
DOI: 10.2500/aap.2007.28.2870
PubMed: 17390754
Links to Exploration step
pubmed:17390754Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">New and emerging infectious diseases.</title>
<author><name sortKey="Spicuzza, Lucia" sort="Spicuzza, Lucia" uniqKey="Spicuzza L" first="Lucia" last="Spicuzza">Lucia Spicuzza</name>
<affiliation><nlm:affiliation>Dipartimento di Medicina Interna e Medicina Specialistica, Sezione Malattie Respiratorie, Università di Catania, Italy. luciaspicuzza@tiscali.it</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Spicuzza, Alessandro" sort="Spicuzza, Alessandro" uniqKey="Spicuzza A" first="Alessandro" last="Spicuzza">Alessandro Spicuzza</name>
</author>
<author><name sortKey="La Rosa, Mario" sort="La Rosa, Mario" uniqKey="La Rosa M" first="Mario" last="La Rosa">Mario La Rosa</name>
</author>
<author><name sortKey="Polosa, Riccardo" sort="Polosa, Riccardo" uniqKey="Polosa R" first="Riccardo" last="Polosa">Riccardo Polosa</name>
</author>
<author><name sortKey="Di Maria, Giuseppe" sort="Di Maria, Giuseppe" uniqKey="Di Maria G" first="Giuseppe" last="Di Maria">Giuseppe Di Maria</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="????"><PubDate><MedlineDate>2007 Jan-Feb</MedlineDate>
</PubDate>
</date>
<idno type="RBID">pubmed:17390754</idno>
<idno type="pmid">17390754</idno>
<idno type="doi">10.2500/aap.2007.28.2870</idno>
<idno type="wicri:Area/PubMed/Corpus">001E63</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001E63</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">New and emerging infectious diseases.</title>
<author><name sortKey="Spicuzza, Lucia" sort="Spicuzza, Lucia" uniqKey="Spicuzza L" first="Lucia" last="Spicuzza">Lucia Spicuzza</name>
<affiliation><nlm:affiliation>Dipartimento di Medicina Interna e Medicina Specialistica, Sezione Malattie Respiratorie, Università di Catania, Italy. luciaspicuzza@tiscali.it</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Spicuzza, Alessandro" sort="Spicuzza, Alessandro" uniqKey="Spicuzza A" first="Alessandro" last="Spicuzza">Alessandro Spicuzza</name>
</author>
<author><name sortKey="La Rosa, Mario" sort="La Rosa, Mario" uniqKey="La Rosa M" first="Mario" last="La Rosa">Mario La Rosa</name>
</author>
<author><name sortKey="Polosa, Riccardo" sort="Polosa, Riccardo" uniqKey="Polosa R" first="Riccardo" last="Polosa">Riccardo Polosa</name>
</author>
<author><name sortKey="Di Maria, Giuseppe" sort="Di Maria, Giuseppe" uniqKey="Di Maria G" first="Giuseppe" last="Di Maria">Giuseppe Di Maria</name>
</author>
</analytic>
<series><title level="j">Allergy and asthma proceedings</title>
<idno type="ISSN">1088-5412</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adrenal Cortex Hormones (therapeutic use)</term>
<term>Antibodies, Viral (analysis)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Communicable Diseases, Emerging</term>
<term>Disease Outbreaks (prevention & control)</term>
<term>Global Health</term>
<term>Humans</term>
<term>Influenza A Virus, H5N1 Subtype (genetics)</term>
<term>Influenza A Virus, H5N1 Subtype (immunology)</term>
<term>Influenza, Human (diagnosis)</term>
<term>Influenza, Human (drug therapy)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (transmission)</term>
<term>Influenza, Human (virology)</term>
<term>Polymerase Chain Reaction</term>
<term>Practice Guidelines as Topic</term>
<term>RNA, Viral (analysis)</term>
<term>SARS Virus (genetics)</term>
<term>SARS Virus (immunology)</term>
<term>Serologic Tests</term>
<term>Severe Acute Respiratory Syndrome (diagnosis)</term>
<term>Severe Acute Respiratory Syndrome (drug therapy)</term>
<term>Severe Acute Respiratory Syndrome (epidemiology)</term>
<term>Severe Acute Respiratory Syndrome (transmission)</term>
<term>Severe Acute Respiratory Syndrome (virology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Antibodies, Viral</term>
<term>RNA, Viral</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adrenal Cortex Hormones</term>
<term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Influenza, Human</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Influenza, Human</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Influenza A Virus, H5N1 Subtype</term>
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H5N1 Subtype</term>
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Disease Outbreaks</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Influenza, Human</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Communicable Diseases, Emerging</term>
<term>Global Health</term>
<term>Humans</term>
<term>Polymerase Chain Reaction</term>
<term>Practice Guidelines as Topic</term>
<term>Serologic Tests</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">New emerging infectious diseases include "severe acute respiratory distress syndrome" (SARS) and avian influenza A H5N1. First cases of SARS, induced by a new strain of coronavirus, were described in China in 2002 and by May 2003 8360 cases and 764 deaths were reported by the World Health Organization. The disease can be transmitted from person to person and at the onset is characterized by nonspecific symptoms such as a fever of > 38 degrees C, dry cough, myalgia, and dyspnea. Adults can develop severe hypoxemia requiring intubation, whereas the course of the disease is generally benign in children. Avian influenza A H5N1 is another emerging infectious disease transmitted from avian species to humans, without clear evidence of transmission from human to human. The widespread outbreaks of H5N1 avian influenza in 2003-2004 have caused major problems for the poultry industry in many Asian countries. On January 2004 the disease crossed over to humans, for the first time in Vietnam, causing 74 deaths to date (mortality rate of 50%) in southeastern countries. Unlike SARS, the avian flu occurs in rural areas, where people live in intimate contact with birds, and many of the victims are children < 5 years of age. As for SARS, the World Health Organization has adopted a global action plan to control avian influenza among chickens and ducks and at the same time to limit the threat of a human flu pandemic.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17390754</PMID>
<DateCompleted><Year>2007</Year>
<Month>04</Month>
<Day>20</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>06</Month>
<Day>08</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1088-5412</ISSN>
<JournalIssue CitedMedium="Print"><Volume>28</Volume>
<Issue>1</Issue>
<PubDate><MedlineDate>2007 Jan-Feb</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Allergy and asthma proceedings</Title>
<ISOAbbreviation>Allergy Asthma Proc</ISOAbbreviation>
</Journal>
<ArticleTitle>New and emerging infectious diseases.</ArticleTitle>
<Pagination><MedlinePgn>28-34</MedlinePgn>
</Pagination>
<Abstract><AbstractText>New emerging infectious diseases include "severe acute respiratory distress syndrome" (SARS) and avian influenza A H5N1. First cases of SARS, induced by a new strain of coronavirus, were described in China in 2002 and by May 2003 8360 cases and 764 deaths were reported by the World Health Organization. The disease can be transmitted from person to person and at the onset is characterized by nonspecific symptoms such as a fever of > 38 degrees C, dry cough, myalgia, and dyspnea. Adults can develop severe hypoxemia requiring intubation, whereas the course of the disease is generally benign in children. Avian influenza A H5N1 is another emerging infectious disease transmitted from avian species to humans, without clear evidence of transmission from human to human. The widespread outbreaks of H5N1 avian influenza in 2003-2004 have caused major problems for the poultry industry in many Asian countries. On January 2004 the disease crossed over to humans, for the first time in Vietnam, causing 74 deaths to date (mortality rate of 50%) in southeastern countries. Unlike SARS, the avian flu occurs in rural areas, where people live in intimate contact with birds, and many of the victims are children < 5 years of age. As for SARS, the World Health Organization has adopted a global action plan to control avian influenza among chickens and ducks and at the same time to limit the threat of a human flu pandemic.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Spicuzza</LastName>
<ForeName>Lucia</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Dipartimento di Medicina Interna e Medicina Specialistica, Sezione Malattie Respiratorie, Università di Catania, Italy. luciaspicuzza@tiscali.it</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Spicuzza</LastName>
<ForeName>Alessandro</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>La Rosa</LastName>
<ForeName>Mario</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Polosa</LastName>
<ForeName>Riccardo</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Di Maria</LastName>
<ForeName>Giuseppe</ForeName>
<Initials>G</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Allergy Asthma Proc</MedlineTA>
<NlmUniqueID>9603640</NlmUniqueID>
<ISSNLinking>1088-5412</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D021821" MajorTopicYN="Y">Communicable Diseases, Emerging</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053124" MajorTopicYN="Y">Influenza A Virus, H5N1 Subtype</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="Y">SARS Virus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012698" MajorTopicYN="N">Serologic Tests</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>21</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year>
<Month>3</Month>
<Day>30</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2007</Year>
<Month>4</Month>
<Day>21</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2007</Year>
<Month>3</Month>
<Day>30</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">17390754</ArticleId>
<ArticleId IdType="doi">10.2500/aap.2007.28.2870</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E63 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001E63 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:17390754 |texte= New and emerging infectious diseases. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:17390754" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |